These three peptides all aim at the same outcome, boosting your body's own growth hormone, but they do it differently and are used differently. If you are trying to make sense of the options, here is how they compare.
Quick answer
Sermorelin, CJC-1295, and ipamorelin are growth hormone secretagogues, meaning they prompt your body to release its own growth hormone rather than supplying it directly. Sermorelin and CJC-1295 work on the GHRH pathway; ipamorelin works on a different pathway (the ghrelin receptor). Sermorelin is the simple, gentle, daily option with an established regulatory history. CJC-1295 lasts longer. Ipamorelin is short-acting and is almost always paired with CJC-1295, because together they hit two pathways for a bigger growth hormone pulse than either alone.
How they work: two pathways
Your body releases growth hormone in response to signals, and these peptides tap into those signals.
- Sermorelin and CJC-1295 are GHRH analogs. They mimic growth hormone-releasing hormone (GHRH), nudging the pituitary gland to release growth hormone through that natural pathway.
- Ipamorelin is a different kind of secretagogue. It acts on the ghrelin receptor, triggering growth hormone release through a separate pathway.
This is the key to understanding why they are combined. Sermorelin or CJC-1295 hits one pathway; ipamorelin hits another. Stimulating both at once produces a stronger, more complete release than one alone.
The three compared
| Feature | Sermorelin | CJC-1295 | Ipamorelin |
|---|---|---|---|
| Type | GHRH analog | GHRH analog | Ghrelin receptor agonist (GH secretagogue) |
| Pathway | GHRH | GHRH | Ghrelin/GH secretagogue |
| Duration | Short, daily dosing | Longer-lasting | Short-acting |
| Typical use | Standalone, gentle | Often stacked with ipamorelin | Almost always stacked with CJC-1295 |
| Regulatory note | Established history as a drug product | Often compounded/research-grade | Often compounded/research-grade |
Sermorelin: the simple, gentle option
Sermorelin is the most straightforward of the three. It is a GHRH analog with a short half-life, so it is dosed daily, and it produces shorter bursts of growth hormone release. Its appeal is a more natural, gradual approach, and it has an established regulatory history as a drug product. For someone who wants a single, gentle peptide rather than a stack, sermorelin is the classic choice.
From the FormBlends catalog
Sermorelin
Bioidentical GHRH analog for natural growth hormone pulsatility · From $175/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
Learn about Sermorelin →CJC-1295: longer-lasting GHRH stimulation
CJC-1295 is also a GHRH analog, but it is engineered to last longer in the body than sermorelin, providing a more sustained elevation in growth hormone. That longer duration is why it is often chosen as the GHRH half of a stack. On its own it provides prolonged stimulation; paired with ipamorelin, it provides the sustained baseline while ipamorelin adds sharper pulses.
Ipamorelin: the pulse partner
Ipamorelin is short-acting and works through the ghrelin/secretagogue pathway, giving quick bursts of growth hormone release. It is rarely used by itself. Instead, it is almost always the "other half" of the CJC-1295 stack. The pairing is popular because CJC-1295 keeps growth hormone elevated while ipamorelin adds the pulsatile bursts, together creating a rhythm meant to support recovery, body composition, and performance.
Which should you consider?
- Want the simplest, gentlest single peptide? Sermorelin, dosed daily.
- Want a stronger, more sustained effect? The CJC-1295 plus ipamorelin stack is the popular modern choice, hitting two pathways.
- Considering ipamorelin alone? Usually not the approach; it is designed to be combined with CJC-1295.
The right choice depends on your goals and should involve a qualified clinician, especially since several of these are compounded or research-grade rather than uniformly FDA-approved.
Important context
These peptides vary in regulatory status and quality. Sermorelin has an established history as a drug product, while CJC-1295 and ipamorelin are often compounded or research-grade. Research-grade peptides bought outside legitimate channels carry purity, sterility, and dosing risks. Anyone considering them should work with a licensed clinician and a legitimate source.
For people whose underlying goals are body composition and weight, those depend heavily on training, protein, sleep, and metabolic health. FormBlends offers compounded semaglutide through licensed prescribers and a provider comparison tool for weight-management options.
Frequently asked questions
What is the difference between sermorelin, CJC-1295, and ipamorelin? Sermorelin and CJC-1295 are GHRH analogs acting on one pathway; ipamorelin acts on the ghrelin receptor, a different pathway. They all stimulate your own growth hormone.
Why are CJC-1295 and ipamorelin used together? They hit two different pathways, so combined they produce a stronger, more complete growth hormone release than either alone.
Is sermorelin better than the CJC-1295 stack? Sermorelin is simpler and gentler with an established history; the stack is stronger and more popular for a bigger effect. The best choice depends on your goals.
Is ipamorelin used alone? Rarely. It is short-acting and almost always paired with CJC-1295 as part of a stack.
How often are these dosed? Sermorelin is typically daily due to its short half-life. CJC-1295 lasts longer. Ipamorelin is short-acting and dosed within its stack. A clinician sets the regimen.
Are these FDA-approved? Sermorelin has an established regulatory history as a drug product. CJC-1295 and ipamorelin are often compounded or research-grade, not uniformly approved.
Are they safe? Safety depends on the specific peptide, dosing, and especially product quality. Research-grade products from unverified sources carry risks. Work with a licensed clinician.
Sources
- National Center for Biotechnology Information: overview of growth hormone secretagogues and GHRH analogs - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2632501/
- U.S. Food and Drug Administration: human drug compounding information - https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
Ready when you are
Sermorelin
Bioidentical GHRH analog for natural growth hormone pulsatility · From $175/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
Learn about Sermorelin →